NASDAQ:CSIICardiovascular Systems Stock Price, Forecast & News

Cardiovascular Systems' stock was trading at $36.32 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CSII stock has increased by 6.6% and is now trading at $38.72. View which stocks have been most impacted by Coronavirus.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardiovascular Systems in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Cardiovascular Systems.

Cardiovascular Systems is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Cardiovascular Systems.

Cardiovascular Systems Inc (NASDAQ:CSII) posted its quarterly earnings data on Tuesday, May, 5th. The medical device company reported ($0.08) EPS for the quarter, topping the consensus estimate of ($0.09) by $0.01. The medical device company earned $61.18 million during the quarter, compared to the consensus estimate of $64 million. Cardiovascular Systems had a negative net margin of 4.04% and a negative return on equity of 7.36%. View Cardiovascular Systems' earnings history.

6 equities research analysts have issued 1 year price targets for Cardiovascular Systems' stock. Their forecasts range from $45.00 to $58.00. On average, they expect Cardiovascular Systems' share price to reach $49.60 in the next year. This suggests a possible upside of 28.1% from the stock's current price. View analysts' price targets for Cardiovascular Systems.

Media coverage about CSII stock has trended extremely negative recently, InfoTrie reports. The research group identifies positive and negative media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Cardiovascular Systems earned a news sentiment score of -4.0 on InfoTrie's scale. They also gave media headlines about the medical device company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news aboutCardiovascular Systems.

Cardiovascular Systems saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 1,490,000 shares, an increase of 5.7% from the April 15th total of 1,410,000 shares. Based on an average daily trading volume, of 328,400 shares, the days-to-cover ratio is presently 4.5 days. Approximately 4.4% of the company's stock are short sold. View Cardiovascular Systems' Current Options Chain.

Some companies that are related to Cardiovascular Systems include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton Dickinson and (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), Teleflex (TFX), Steris (STE), Hologic (HOLX) and Masimo (MASI). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardiovascular Systems investors own include AbbVie (ABBV), Gilead Sciences (GILD), Netflix (NFLX), Adobe (ADBE), Advanced Micro Devices (AMD), Activision Blizzard (ATVI), Medtronic (MDT), Pfizer (PFE), Procter & Gamble (PG) and Target (TGT).

Cardiovascular Systems trades on the NASDAQ under the ticker symbol "CSII."

Cardiovascular Systems' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Brown Capital Management LLC (16.63%), BlackRock Inc. (15.82%), Champlain Investment Partners LLC (7.63%), Janus Henderson Group PLC (3.84%), Wellington Management Group LLP (3.81%) and State Street Corp (3.49%). Company insiders that own Cardiovascular Systems stock include Alexander Rosenstein, Jeffrey S Points, Martha Goldberg Aronson, Sandra Sedo and Scott R Ward. View institutional ownership trends for Cardiovascular Systems.

CSII stock was sold by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, Morgan Stanley, Morgan Stanley, Russell Investments Group Ltd., Parametric Portfolio Associates LLC, Acadian Asset Management LLC, State Board of Administration of Florida Retirement System, and First Trust Advisors LP. Company insiders that have sold Cardiovascular Systems company stock in the last year include Alexander Rosenstein, and Sandra Sedo. View insider buying and selling activity for Cardiovascular Systems.

CSII stock was purchased by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Peregrine Capital Management LLC, Champlain Investment Partners LLC, Balyasny Asset Management LLC, Invesco Ltd., BlackRock Inc., Assenagon Asset Management S.A., and Nuveen Asset Management LLC. Company insiders that have bought Cardiovascular Systems stock in the last two years include Martha Goldberg Aronson, and Scott R Ward. View insider buying and selling activity for Cardiovascular Systems.

Shares of CSII can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CSII stock can currently be purchased for approximately $38.72.

Cardiovascular Systems has a market capitalization of $1.37 billion and generates $248.02 million in revenue each year. The medical device company earns $-250,000.00 in net income (profit) each year or ($0.01) on an earnings per share basis. Cardiovascular Systems employs 652 workers across the globe.

The official website for Cardiovascular Systems is www.csi360.com.

Cardiovascular Systems' mailing address is 1225 OLD HWY 8 NW, ST. PAUL MN, 55112. The medical device company can be reached via phone at 651-259-1600 or via email at [email protected]